-
Roche’s focus is the search for innovative new medicines and diagnostics by funding and conducting R&D into serious and life-threatening diseases, investing over 9 bn Swiss francs in 2009.
-
Almost 270,000 people took part in our clinical trials globally in 2009, receiving access to the latest treatments for cancer, arthritis and other diseases?
-
Roche forges partnerships with governments and other healthcare providers because medicines and diagnostics are only one component of the healthcare puzzle?
-
The CARE programme which in partnership with PharmAccess Foundation established HIV treatment programmes across Africa and educational events reaching over 600 healthcare professionals in 29 countries across Africa and Asia?
-
The Phelophepa Health Care Train is a mobile clinic bringing medical care to rural South Africa, reaching out to people who have no access to basic medical services?
-
Each year, the Phelophepa Health Care Train delivers health care to more than 45,000 rural South Africans in regions where there is just one doctor for every 4,000 patients.
-
The Roche Children’s Walk has enabled 3,000 children from 60 villages in Malawi to receive hot meals, health check-ups and education at day centres.
-
AIDS Technology Transfer Initiative, launched in 2006 shares, the knowledge Roche has developed to manufacture saquinavir with local manufacturers in sub-Saharan Africa and Least Developed Countries free of charge?
-
Since 2002, we have supplied our HIV/AIDS medicines, Invirase and Viracept, at no profit prices for people living in Least Developed Countries and sub-Saharan Africa?
-
Our no profit, no patent policies for Roche’s HIV medicines apply to 70% of all people with HIV/AIDS worldwide?
-
Our Employee Secondment Policy enables our employees to contribute their skills and transfer their expertise to health related projects primarily in the world’s Least Developed Countries?
-
As announced in April 2010, Roche and the International Atomic Energy Agency have launched a joint initiative called EDUCARE to provide oncology training and education to healthcare workers in Africa. The intiative is a response to rapidly growing cancer rates in Africa and will be tailored to the region’s specific needs.
-
Roche has trained apprentices since the 1950's and every year in Basel alone some 300 young people are trained in 14 different professions?
-
more than 140 nationalities are represented at Roche?
-
in 2009 Roche invested around 2.16 million hours in skills training and education, or nearly 26 hours per employee?
-
People from over 70 countries – from Australia to Uruguay to South Africa – work for Roche in Switzerland?
-
In 2009 more than one-third of all Roche managers were women.
-
Interesting works of art decorate work and recreation areas as well as corridors in Roche buildings all over the world?
-
Roche has been an active patron of contemporary art and cultural projects since its beginnings in 1896 ?
-
Roche has had a corporate architecture before it had its own corporate design?
-
In 1926, 30-year old Alice Keller took over a position at Roche Tokyo to come back in 1939 as a director?
-
Roche is still majority owned by the descendants of the founder family?
-
Roche is a valued partner to more than 80 companies worldwide to bring new complementary technologies and potential products into the company?
-
Roche in 2009 has been rated as the new Super Sector Leader in Healthcare on the Dow Jones Sustainability Index, placing Roche as the most sustainable healthcare company worldwide?
-
Patients can access Roche products through doctors, hospitals, laboratories and pharmacies in roughly 180 countries?
-
Roche is the world's biggest producer of biopharmaceuticals?
-
Roche produces more than 150 medicines in thousands of presentations around the world?
-
Roche is the only company that brought 5 cancer treatments with proven survival benefits to patients?
-
Each day about 7000 scientists work for Roche on developing new medicines?
-
Roche spends each day around 23 million Swiss Francs on Research & Development?
-
Roche has opened new research and development centers in China in 2004 and 2007? However Roche started its business in China much earlier by founding the subsidiary 'Hoffmann-La Roche Limited Company Shanghai' already in 1935
-
Roche invests in stem cell research, one of the most promising approaches in developing new treatments for e.g. autoimmune, CNS diseases?
-
Roche accounts for 9% of total Swiss expenditures on research and development? That’s one in every 11 Swiss Francs spent on research and development in Switzerland.
-
It takes around 7 million hours of work to discover and develop one medicine
-
It takes around 6587 experiments to discover and develop one medicine
-
Discovering and developing a new medicine costs over 1 billion Swss francs, with additional costs after the medicine goes on the market.